BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35358481)

  • 1. sVmKTx, a transcriptome analysis-based synthetic peptide analogue of Vm24, inhibits Kv1.3 channels of human T cells with improved selectivity.
    Csoti A; Del Carmen Nájera Meza R; Bogár F; Tajti G; Szanto TG; Varga Z; Gurrola GB; Tóth GK; Possani LD; Panyi G
    Biochem Pharmacol; 2022 May; 199():115023. PubMed ID: 35358481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Margatoxin is a non-selective inhibitor of human Kv1.3 K+ channels.
    Bartok A; Toth A; Somodi S; Szanto TG; Hajdu P; Panyi G; Varga Z
    Toxicon; 2014 Sep; 87():6-16. PubMed ID: 24878374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K
    Veytia-Bucheli JI; Jiménez-Vargas JM; Melchy-Pérez EI; Sandoval-Hernández MA; Possani LD; Rosenstein Y
    Cell Commun Signal; 2018 Aug; 16(1):45. PubMed ID: 30107837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes.
    Bagdány M; Batista CV; Valdez-Cruz NA; Somodi S; Rodriguez de la Vega RC; Licea AF; Varga Z; Gáspár R; Possani LD; Panyi G
    Mol Pharmacol; 2005 Apr; 67(4):1034-44. PubMed ID: 15615696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.
    Varga Z; Gurrola-Briones G; Papp F; Rodríguez de la Vega RC; Pedraza-Alva G; Tajhya RB; Gaspar R; Cardenas L; Rosenstein Y; Beeton C; Possani LD; Panyi G
    Mol Pharmacol; 2012 Sep; 82(3):372-82. PubMed ID: 22622363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility.
    Bartok A; Fehér K; Bodor A; Rákosi K; Tóth GK; Kövér KE; Panyi G; Varga Z
    Sci Rep; 2015 Dec; 5():18397. PubMed ID: 26689143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tst26, a novel peptide blocker of Kv1.2 and Kv1.3 channels from the venom of Tityus stigmurus.
    Papp F; Batista CV; Varga Z; Herceg M; Román-González SA; Gaspar R; Possani LD; Panyi G
    Toxicon; 2009 Sep; 54(4):379-89. PubMed ID: 19500613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): A Scorpion Toxin That Inhibits Voltage-Gated K
    Naseem MU; Gurrola-Briones G; Romero-Imbachi MR; Borrego J; Carcamo-Noriega E; Beltrán-Vidal J; Zamudio FZ; Shakeel K; Possani LD; Panyi G
    Toxins (Basel); 2023 Jan; 15(1):. PubMed ID: 36668861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, function, and chemical synthesis of Vaejovis mexicanus peptide 24: a novel potent blocker of Kv1.3 potassium channels of human T lymphocytes.
    Gurrola GB; Hernández-López RA; Rodríguez de la Vega RC; Varga Z; Batista CV; Salas-Castillo SP; Panyi G; del Río-Portilla F; Possani LD
    Biochemistry; 2012 May; 51(19):4049-61. PubMed ID: 22540187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Kv1.3 K
    Varga Z; Tajti G; Panyi G
    Biol Futur; 2021 Mar; 72(1):75-83. PubMed ID: 34554500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
    Ye F; Hu Y; Yu W; Xie Z; Hu J; Cao Z; Li W; Wu Y
    Toxins (Basel); 2016 Apr; 8(4):115. PubMed ID: 27104568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Kv1.3 channel blocker Vm24 enhances muscle glucose transporter 4 mobilization but does not reduce body-weight gain in diet-induced obese male rats.
    Jaimes-Hoy L; Gurrola GB; Cisneros M; Joseph-Bravo P; Possani LD; Charli JL
    Life Sci; 2017 Jul; 181():23-30. PubMed ID: 28549558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of a potent peptide inhibitor designed for Kv1.3 channel, a therapeutic target of autoimmune disease.
    Han S; Yi H; Yin SJ; Chen ZY; Liu H; Cao ZJ; Wu YL; Li WX
    J Biol Chem; 2008 Jul; 283(27):19058-65. PubMed ID: 18480054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, molecular modeling, and function of the novel potassium channel blocker urotoxin isolated from the venom of the Australian scorpion Urodacus yaschenkoi.
    Luna-Ramírez K; Bartok A; Restano-Cassulini R; Quintero-Hernández V; Coronas FI; Christensen J; Wright CE; Panyi G; Possani LD
    Mol Pharmacol; 2014 Jul; 86(1):28-41. PubMed ID: 24723491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life.
    Edwards W; Fung-Leung WP; Huang C; Chi E; Wu N; Liu Y; Maher MP; Bonesteel R; Connor J; Fellows R; Garcia E; Lee J; Lu L; Ngo K; Scott B; Zhou H; Swanson RV; Wickenden AD
    J Biol Chem; 2014 Aug; 289(33):22704-22714. PubMed ID: 24939846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases.
    Rashid MH; Huq R; Tanner MR; Chhabra S; Khoo KK; Estrada R; Dhawan V; Chauhan S; Pennington MW; Beeton C; Kuyucak S; Norton RS
    Sci Rep; 2014 Mar; 4():4509. PubMed ID: 24676092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker.
    Yang XF; Yang Y; Lian YT; Wang ZH; Li XW; Cheng LX; Liu JP; Wang YF; Gao X; Liao YH; Wang M; Zeng QT; Liu K
    PLoS One; 2012; 7(4):e36379. PubMed ID: 22558454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid phase synthesis, NMR structure determination of α-KTx3.8, its in silico docking to Kv1.x potassium channels, and electrophysiological analysis provide insights into toxin-channel selectivity.
    Kohl B; Rothenberg I; Ali SA; Alam M; Seebohm G; Kalbacher H; Voelter W; Stoll R
    Toxicon; 2015 Jul; 101():70-8. PubMed ID: 25953725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity.
    Naseem MU; Carcamo-Noriega E; Beltrán-Vidal J; Borrego J; Szanto TG; Zamudio FZ; Delgado-Prudencio G; Possani LD; Panyi G
    J Gen Physiol; 2022 Aug; 154(8):. PubMed ID: 35699659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.
    Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS
    FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.